Status:
COMPLETED
Colchicine Randomized Double-Blind Controlled Crossover Study in Behcet's Disease
Lead Sponsor:
Tehran University of Medical Sciences
Conditions:
Behcet's Syndrome
Eligibility:
All Genders
14-60 years
Phase:
PHASE2
Brief Summary
Colchicine was first used in Behcet's Disease (BD), in 1977. There are controversial reports of the efficacy of Colchicine in BD. For some experts the unresponsiveness of some patients could be explai...
Detailed Description
Patients: They were selected as consecutive patients. The entry criteria was: age between 14 and 60 years, confirmed diagnosis of Behcet's Disease, absence of major organ involvement (eye, brain, lun...
Eligibility Criteria
Inclusion
- Patient's who fulfilled the International Criteria for Behcet's Disease.
Exclusion
- major organ involvement
- Hypersensitivity reaction
Key Trial Info
Start Date :
August 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2006
Estimated Enrollment :
169 Patients enrolled
Trial Details
Trial ID
NCT00700297
Start Date
August 1 2002
End Date
May 1 2006
Last Update
June 18 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rheumatology research Center, Tehran UMS
Tehran, Tehran Province, Iran, 14114